A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Conditions
Atopic Dermatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Leo Pharma Investigational site, Birmingham, Alabama, United States
Leo Pharma Investigational site, North Little Rock, Arkansas, United States
Leo Pharma Investigational site, Palo Alto, California, United States
Leo Pharma Investigational site, Sacramento, California, United States
Leo Pharma Investigational site, San Diego, California, United States
Leo Pharma Investigational site, San Diego, California, United States
Leo Pharma Investigational site, Jacksonville, Florida, United States
Leo Pharma Investigational site, Miami, Florida, United States
Leo Pharma Investigational site, Tampa, Florida, United States
Leo Pharma Investigational site, Macon, Georgia, United States
Leo Pharma Investigational site, Waterford, Michigan, United States
Leo Pharma Investigational site, Tulsa, Oklahoma, United States
Leo Pharma Investigational site, Portland, Oregon, United States
Leo Pharma Investigational site, Charleston, South Carolina, United States
Leo Pharma Investigational site, Norfolk, Virginia, United States
Leo Pharma Investigational site, Brussels, Belgium
Leo Pharma Investigational site, Ghent, Belgium
Leo Pharma Investigational site, Leuven, Belgium
Leo Pharma Investigational site, Liège, Belgium
Leo Pharma Investigational site, Burlington, Canada
Leo Pharma Investigational site, Calgary, Canada
Leo Pharma Investigational site, Calgary, Canada
Leo Pharma Investigational site, Edmonton, Canada
Leo Pharma Investigational site, Edmonton, Canada
Leo Pharma Investigational site, Hamilton, Canada
Leo Pharma Investigational site, Niagara Falls, Canada
Leo Pharma Investigational site, Saskatoon, Canada
Leo Pharma Investigational site, Windsor, Canada
Leo Pharma Investigational site, Winnipeg, Canada
Leo Pharma Investigational site, Rijeka, Croatia
Leo Pharma Investigational site, Zagreb, Croatia
Leo Pharma Investigational site, Zagreb, Croatia
Leo Pharma Investigational site, Buxtehude, Germany
Leo Pharma Investigational site, Dresden, Germany
Leo Pharma Investigational site, Mainz, Germany
Leo Pharma Investigational site, Osnabrück, Germany
Leo Pharma Investigational site, Tübingen, Germany
Leo Pharma Investigational site, Wuppertal, Germany
Leo Pharma Investigational site, Cork, Ireland
Leo Pharma Investigational site, Crumlin, Ireland
Leo Pharma Investigational site, Ancona, Italy
Leo Pharma Investigational site, Brescia, Italy
Leo Pharma Investigational site, Padova, Italy
Leo Pharma Investigational site, Roma, Italy
Leo Pharma Investigational site, Rome, Italy
Leo Pharma Investigational site, Utrecht, Netherlands
Leo Pharma Investigational site, Gdansk, Poland
Leo Pharma Investigational site, Krakow, Poland
Leo Pharma Investigational site, Lodz, Poland
Leo Pharma Investigational site, Ostrowiec Świętokrzyski, Poland
Leo Pharma Investigational site, Rzeszów, Poland
Leo Pharma Investigational site, Tarnów, Poland
Leo Pharma Investigational site, Warsaw, Poland
Leo Pharma Investigational site, Warsaw, Poland
Leo Pharma Investigational site, Brasov, Romania
Leo Pharma Investigational site, Iași, Romania
Leo Pharma Investigational site, Ansan-si, South Korea
Leo Pharma Investigational site, Gwangju, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Seoul, South Korea
Leo Pharma Investigational site, Alicante, Spain
Leo Pharma Investigational site, Madrid, Spain
Leo Pharma Investigational site, Valencia, Spain
Leo Pharma Investigational site, Lincoln, United Kingdom
Leo Pharma Investigational site, London, United Kingdom
Leo Pharma Investigational site, Sheffield, United Kingdom
Leo Pharma Investigational site, Southampton, United Kingdom
Study leads
Medical Expert
Study Director
LEO Pharma